Detailed answers about INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C., including incorporation, status, business activity, and accounts information.
When was INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. founded?
INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. was officially incorporated on 12 May 2026 and is registered under company number 17212824. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C.?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C.?
INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C.'s current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. do?
INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. operates in the following sectors: 85590 - Other education n.e.c., 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C.'s registered address?
The registered office address of INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. is 38 Cotton Way, Havant, England, PO9 3FT. This is the official address filed with Companies House for legal and statutory correspondence.
Is INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. financially stable?
Financial accounts for INTERNATIONAL UROLOGY CANCER SUMMIT C.I.C. are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.